Exact Sciences launches Cancerguard multi-cancer blood test with Quest Diagnostics partnership (fiercebiotech.com)

• Exact Sciences launches Cancerguard blood test for multi-cancer early detection
• Partnership with Quest Diagnostics for sample collection and lab services
• Intensifies competition with Grail Galleri and other multi-cancer tests

"Exact Sciences began commercial rollout of its Cancerguard multi-cancer early detection blood test. The test uses multiomics technology to screen for multiple cancer types from a single blood draw. Cancerguard is being offered through a partnership with Quest Diagnostics, which will handle sample collection and laboratory processing. This launch positions Exact Sciences in direct competition with Grail’s Galleri test and others in the multi-cancer screening market."